DK1756064T3 - Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder - Google Patents

Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder

Info

Publication number: DK1756064T3
Authority: DK; Denmark
Prior art keywords: compounds; methods; compositions containing; pyrazole derivatives; pyrazole
Prior art date: 2004-06-04

Application number

DK05754758T

Other languages

English (en)

Inventor

Emma R Parmee

Yusheng Xiong

Jian Guo

Rui Liang

Linda Brockunier

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-04

Filing date

2005-05-31

Publication date

2008-09-22

2005-05-31 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

2008-09-22 Application granted granted Critical

2008-09-22 Publication of DK1756064T3 publication Critical patent/DK1756064T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Child & Adolescent Psychology (AREA)
Ophthalmology & Optometry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK05754758T 2004-06-04 2005-05-31 Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder DK1756064T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US57711604P	2004-06-04	2004-06-04
PCT/US2005/018828 WO2005121097A2 (en)	2004-06-04	2005-05-31	Pyrazole derivatives, compositions containing such compounds and methods of use

Publications (1)

Publication Number	Publication Date
DK1756064T3 true DK1756064T3 (da)	2008-09-22

Family

ID=35335786

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05754758T DK1756064T3 (da)	2004-06-04	2005-05-31	Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder

Country Status (34)

Country	Link
US (2)	US7598285B2 (da)
EP (1)	EP1756064B1 (da)
JP (2)	JP4108739B2 (da)
CN (1)	CN1964947A (da)
AR (2)	AR049291A1 (da)
AT (1)	ATE395338T1 (da)
AU (2)	AU2005252183B2 (da)
BR (1)	BRPI0511703B8 (da)
CA (1)	CA2566945C (da)
CR (1)	CR8766A (da)
CY (1)	CY1108544T1 (da)
DE (1)	DE602005006806D1 (da)
DK (1)	DK1756064T3 (da)
EA (1)	EA012431B1 (da)
EC (1)	ECSP067062A (da)
ES (1)	ES2306165T3 (da)
GE (1)	GEP20094605B (da)
HR (1)	HRP20080311T3 (da)
IL (1)	IL179754A (da)
MA (1)	MA28673B1 (da)
MX (1)	MXPA06014084A (da)
MY (1)	MY143599A (da)
NI (1)	NI200600290A (da)
NO (1)	NO339149B1 (da)
NZ (1)	NZ551405A (da)
PE (1)	PE20060427A1 (da)
PL (1)	PL1756064T3 (da)
PT (1)	PT1756064E (da)
SI (1)	SI1756064T1 (da)
TN (1)	TNSN06397A1 (da)
TW (1)	TWI293952B (da)
UA (1)	UA85884C2 (da)
WO (1)	WO2005121097A2 (da)
ZA (1)	ZA200609489B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2004210127B2 (en)	2003-01-27	2009-10-01	Merck Sharp & Dohme Corp.	Substituted pyrazoles, compositions containing such compounds and methods of use
UA85884C2 (uk)	2004-06-04	2009-03-10	Мерк Енд Ко., Інк.	Похідні піразолу, композиція, що містить ці сполуки, і спосіб застосування (варіанти)
CA2574147A1 (en) *	2004-07-22	2006-02-09	Linda Brockunier	Substituted pyrazoles, compositions containing such compounds and methods of use
AU2006276072A1 (en)	2005-07-26	2007-02-08	Merck Sharp & Dohme Corp.	Process for synthesizing a substituted pyrazole
AR056574A1 (es) *	2005-10-19	2007-10-10	Merck & Co Inc	Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
EP2114891A1 (en) *	2007-01-17	2009-11-11	Laboratorios Del. Dr. Esteve, S.A.	Substituted pyrazoline compounds with acat inhibition activity
DK2129654T3 (da)	2007-02-09	2014-08-25	Metabasis Therapeutics Inc	Antagonister af glucagonreceptoren
EP2170337A4 (en) *	2007-06-28	2013-12-18	Abbvie Inc	NEW TRIAZOLOPYRIDAZINE
US8232413B2 (en) *	2007-09-12	2012-07-31	Merck Sharp & Dohme Corp.	Process for the production of a crystalline glucagon receptor antagonist compound
JP5465658B2 (ja)	2008-03-05	2014-04-09	武田薬品工業株式会社	複素環化合物
US8722094B2 (en)	2008-03-11	2014-05-13	Aska Pharmaceutical Co., Ltd.	Solid dispersion and pharmaceutical composition of the same, and production processes thereof
EP2291358B1 (en)	2008-05-16	2018-03-28	Merck Sharp & Dohme Corp.	Glucagon receptor antagonists, compositions, and methods for their use
DK2799428T3 (da)	2008-08-13	2017-02-20	Metabasis Therapeutics Inc	Glucagon-antagonister
RU2008135294A (ru) *	2008-08-29	2010-03-10	Дик Корпорейшн (Jp)	Нафталиновые производные
WO2010030722A1 (en) *	2008-09-15	2010-03-18	Merck Sharp & Dohme Corp.	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
CA2738663A1 (en) *	2008-10-03	2010-04-08	Schering Corporation	Spiro-imidazolone derivatives as glucagon receptor antagonists
US8324384B2 (en)	2009-02-12	2012-12-04	Merck Sharp & Dohme Corp.	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2010098994A1 (en)	2009-02-25	2010-09-02	Merck Sharp & Dohme Corp.	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2010144664A1 (en) *	2009-06-12	2010-12-16	Schering Corporation	Thiophenes as glucagon receptor antagonists, compositions, and methods for their use
EP2480077B1 (en)	2009-09-22	2015-02-18	Merck Sharp & Dohme Corp.	Pyrrolidines as glucagon receptor antagonists, compositions, and methods for their use
MX2013006768A (es)	2010-12-23	2013-07-22	Pfizer	Moduladores de receptor de glucagon.
ES2597972T3 (es)	2011-02-08	2017-01-24	Pfizer Inc	Modulador del receptor de glucagón
WO2013014569A1 (en)	2011-07-22	2013-01-31	Pfizer Inc.	Quinolinyl glucagon receptor modulators
TW201427658A (zh)	2012-12-10	2014-07-16	Merck Sharp & Dohme	藉由投予升糖素受體拮抗劑及膽固醇吸收抑制劑治療糖尿病之方法
US9649294B2 (en)	2013-11-04	2017-05-16	Merck Sharp & Dohme Corp.	Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
CN103933032B (zh) *	2013-12-30	2019-08-23	北京赛林泰医药技术有限公司	作为抗癌药物的吡唑类衍生物的使用方法和用途
JP2017519000A (ja)	2014-06-12	2017-07-13	リガンド・ファーマシューティカルズ・インコーポレイテッド	グルカゴンアンタゴニスト
US10995146B2 (en)	2016-08-30	2021-05-04	Regeneron Pharmaceuticals, Inc.	Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
TWI763705B (zh) *	2016-09-06	2022-05-11	比利時商健生藥品公司	可作為升糖素受體拮抗劑之吲哚衍生物
US20190248888A1 (en)	2016-10-20	2019-08-15	Regeneron Pharmaceuticals, Inc.	Methods of lowering blood glucose levels
CA3071387A1 (en)	2017-08-22	2019-02-28	Regeneron Pharmaceuticals, Inc.	Methods of treating urea cycle disorders by interfering with glucagon receptor signaling
CN111954560A (zh)	2018-02-13	2020-11-17	配体药物公司	胰高血糖素受体拮抗剂

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9303993D0 (en)	1993-02-26	1993-04-14	Fujisawa Pharmaceutical Co	New heterocyclic derivatives
JPH11514651A (ja)	1995-10-31	1999-12-14	メルクエンドカンパニーインコーポレーテッド	置換ピリジルピロール、前記化合物を含む組成物及び使用方法
AR008789A1 (es)	1996-07-31	2000-02-23	Bayer Corp	Piridinas y bifenilos substituidos
US5776954A (en)	1996-10-30	1998-07-07	Merck & Co., Inc.	Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
EP0959885A4 (en)	1996-11-20	2002-07-17	Merck & Co Inc	TRIARYL SUBSTITUTED IMIDAZOLES AND METHODS OF USE
JP2000514088A (ja)	1996-11-20	2000-10-24	メルクエンドカンパニーインコーポレーテッド	グルカゴンアンタゴニストとしてのトリアリール置換イミダゾール
CA2271963A1 (en)	1996-11-20	1998-05-28	Linda L. Chang	Triaryl substituted imidazoles, compositions containing such compounds and methods of use
DE69719544T2 (de)	1996-12-12	2003-11-06	Banyu Pharmaceutical Co., Ltd.	Pyrazolderivate
EP0979077A1 (en)	1997-04-18	2000-02-16	G.D. Searle & Co.	Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
US6613942B1 (en)	1997-07-01	2003-09-02	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
CN1282319A (zh)	1997-10-09	2001-01-31	小野药品工业株式会社	氨基丁酸衍生物
IL136711A0 (en)	1997-12-19	2001-06-14	Amgen Inc	Substituted pyridine and pyridazine compounds and their pharmaceutical use
DE69939481D1 (de)	1998-09-17	2008-10-16	Bristol Myers Squibb Co	Methode zur behandlung von diabetes die einen ap2-inhibitor und dazugehörige kombinationen verwendet
US6503949B1 (en)	1999-05-17	2003-01-07	Noro Nordisk A/S	Glucagon antagonists/inverse agonists
CN1229358C (zh)	1999-08-10	2005-11-30	日本拜耳农药株式会社	新的四唑啉酮衍生物
ATE271049T1 (de) *	1999-11-10	2004-07-15	Takeda Chemical Industries Ltd	Fünfgliedrige n-heterocyclen mit hypoglykämischer und hypolipidemischer wirkung
US6562807B2 (en)	2000-06-23	2003-05-13	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
WO2002008188A1 (en) *	2000-07-25	2002-01-31	Merck & Co., Inc.	N-substituted indoles useful in the treatment of diabetes
WO2002040444A1 (en)	2000-11-17	2002-05-23	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
US20030203946A1 (en)	2000-11-17	2003-10-30	Carsten Behrens	Glucagon antagonists/inverse agonists
ITMI20010733A1 (it)	2001-04-05	2002-10-05	Recordati Chem Pharm	Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
US6881746B2 (en)	2001-12-03	2005-04-19	Novo Nordick A/S	Glucagon antagonists/inverse agonists
US6762318B2 (en)	2001-12-03	2004-07-13	Novo Nordisk A/S	Glucagon antagonists
AU2002351730A1 (en)	2001-12-19	2003-06-30	Novo Nordisk A/S	Glucagon receptor antagonists/inverse agonists
AU2002347022A1 (en)	2001-12-20	2003-07-09	Novo Nordisk A/S	Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
BR0307409A (pt)	2002-02-01	2004-12-28	Dainippon Pharmaceutical Co	Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico
WO2004009158A2 (en)	2002-07-19	2004-01-29	Baxter International Inc.	Systems and methods for performing peritoneal dialysis
EP1400243A1 (en)	2002-09-19	2004-03-24	Tanabe Seiyaku Co., Ltd.	Calcium-activated K channel activator
JP2006509015A (ja) *	2002-12-04	2006-03-16	メルク　エンド　カムパニー　インコーポレーテッド	スピロ環尿素、そのような化合物を含有する組成物、及び使用方法
AU2004210127B2 (en)	2003-01-27	2009-10-01	Merck Sharp & Dohme Corp.	Substituted pyrazoles, compositions containing such compounds and methods of use
EP1633354B1 (en) *	2003-04-14	2008-01-23	The Institutes for Pharmaceutical Discovery, LLC	N-(((((1,3-thiazol-2-yl)amino)carbonyl)phenyl)sulfonyl)phenylalanine derivatives and related compounds for the treatment of diabetes
WO2004100875A2 (en) *	2003-05-09	2004-11-25	Merck & Co., Inc.	Benzimidazoles, compositions containing such compounds and methods of use
UA85884C2 (uk) *	2004-06-04	2009-03-10	Мерк Енд Ко., Інк.	Похідні піразолу, композиція, що містить ці сполуки, і спосіб застосування (варіанти)
CA2574147A1 (en) *	2004-07-22	2006-02-09	Linda Brockunier	Substituted pyrazoles, compositions containing such compounds and methods of use
AR056574A1 (es) *	2005-10-19	2007-10-10	Merck & Co Inc	Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso

2005
- 2005-05-31 UA UAA200700111A patent/UA85884C2/uk unknown
- 2005-05-31 MX MXPA06014084A patent/MXPA06014084A/es active IP Right Grant
- 2005-05-31 PL PL05754758T patent/PL1756064T3/pl unknown
- 2005-05-31 DE DE602005006806T patent/DE602005006806D1/de active Active
- 2005-05-31 EA EA200602196A patent/EA012431B1/ru not_active IP Right Cessation
- 2005-05-31 PT PT05754758T patent/PT1756064E/pt unknown
- 2005-05-31 ES ES05754758T patent/ES2306165T3/es active Active
- 2005-05-31 WO PCT/US2005/018828 patent/WO2005121097A2/en active IP Right Grant
- 2005-05-31 GE GEAP20059788A patent/GEP20094605B/en unknown
- 2005-05-31 DK DK05754758T patent/DK1756064T3/da active
- 2005-05-31 JP JP2007515416A patent/JP4108739B2/ja not_active Expired - Fee Related
- 2005-05-31 BR BRPI0511703A patent/BRPI0511703B8/pt not_active IP Right Cessation
- 2005-05-31 SI SI200530296T patent/SI1756064T1/sl unknown
- 2005-05-31 NZ NZ551405A patent/NZ551405A/en not_active IP Right Cessation
- 2005-05-31 MY MYPI20052470A patent/MY143599A/en unknown
- 2005-05-31 CN CNA2005800182634A patent/CN1964947A/zh active Pending
- 2005-05-31 AU AU2005252183A patent/AU2005252183B2/en not_active Ceased
- 2005-05-31 CA CA2566945A patent/CA2566945C/en not_active Expired - Fee Related
- 2005-05-31 EP EP05754758A patent/EP1756064B1/en active Active
- 2005-05-31 AT AT05754758T patent/ATE395338T1/de active
- 2005-06-02 PE PE2005000624A patent/PE20060427A1/es not_active Application Discontinuation
- 2005-06-02 AR ARP050102266A patent/AR049291A1/es active IP Right Grant
- 2005-06-03 TW TW094118496A patent/TWI293952B/zh not_active IP Right Cessation
- 2005-06-03 US US11/144,332 patent/US7598285B2/en active Active
2006
- 2006-11-15 ZA ZA200609489A patent/ZA200609489B/en unknown
- 2006-11-23 CR CR8766A patent/CR8766A/es unknown
- 2006-11-30 NI NI200600290A patent/NI200600290A/es unknown
- 2006-11-30 IL IL179754A patent/IL179754A/en active IP Right Grant
- 2006-12-01 TN TNP2006000397A patent/TNSN06397A1/en unknown
- 2006-12-04 EC EC2006007062A patent/ECSP067062A/es unknown
- 2006-12-20 MA MA29545A patent/MA28673B1/fr unknown
2007
- 2007-01-04 NO NO20070073A patent/NO339149B1/no not_active IP Right Cessation
2008
- 2008-02-05 JP JP2008025035A patent/JP4733153B2/ja not_active Expired - Fee Related
- 2008-07-01 HR HR20080311T patent/HRP20080311T3/xx unknown
- 2008-07-21 CY CY20081100762T patent/CY1108544T1/el unknown
- 2008-09-30 AU AU2008229701A patent/AU2008229701C1/en not_active Ceased
2009
- 2009-03-17 US US12/405,600 patent/US7799818B2/en active Active
2012
- 2012-11-20 AR ARP120104354A patent/AR088919A2/es unknown

Also Published As

Publication number	Publication date
EP1756064A2 (en)	2007-02-28
TW200604179A (en)	2006-02-01
UA85884C2 (uk)	2009-03-10
MA28673B1 (fr)	2007-06-01
AU2008229701C1 (en)	2010-07-29
BRPI0511703B8 (pt)	2021-05-25
EP1756064B1 (en)	2008-05-14
JP4733153B2 (ja)	2011-07-27
JP2008505062A (ja)	2008-02-21
JP2008150388A (ja)	2008-07-03
HRP20080311T3 (en)	2008-07-31
US20090176854A1 (en)	2009-07-09
PL1756064T3 (pl)	2008-11-28
PT1756064E (pt)	2008-07-22
CR8766A (es)	2007-08-28
NO20070073L (no)	2007-03-05
MY143599A (en)	2011-06-15
AU2008229701B2 (en)	2010-03-04
AR088919A2 (es)	2014-07-16
JP4108739B2 (ja)	2008-06-25
CN1964947A (zh)	2007-05-16
BRPI0511703A (pt)	2008-01-08
WO2005121097A2 (en)	2005-12-22
ECSP067062A (es)	2007-01-26
EA200602196A1 (ru)	2007-06-29
IL179754A0 (en)	2007-05-15
NZ551405A (en)	2009-06-26
TWI293952B (en)	2008-03-01
EA012431B1 (ru)	2009-10-30
US7799818B2 (en)	2010-09-21
WO2005121097A3 (en)	2006-02-16
MXPA06014084A (es)	2007-02-15
GEP20094605B (en)	2009-02-10
CA2566945C (en)	2010-09-21
ATE395338T1 (de)	2008-05-15
BRPI0511703B1 (pt)	2018-07-17
AU2005252183A1 (en)	2005-12-22
CY1108544T1 (el)	2014-04-09
NO339149B1 (no)	2016-11-14
NI200600290A (es)	2007-08-07
IL179754A (en)	2013-12-31
SI1756064T1 (sl)	2008-12-31
AR049291A1 (es)	2006-07-12
PE20060427A1 (es)	2006-06-19
US20050272794A1 (en)	2005-12-08
US7598285B2 (en)	2009-10-06
ES2306165T3 (es)	2008-11-01
DE602005006806D1 (de)	2008-06-26
AU2008229701A1 (en)	2008-10-30
CA2566945A1 (en)	2005-12-22
TNSN06397A1 (en)	2008-02-22
ZA200609489B (en)	2007-10-31
AU2005252183B2 (en)	2008-07-17

Publication	Publication Date	Title
DK1756064T3 (da)	2008-09-22	Pyrazolderivater, sammensætninger indeholdende sådanne forbindelser og anvendelsesmetoder
NO20082256L (no)	2008-07-15	Pyrazolderivater, preparater som inneholder slike forbindelser, og fremgangsmåter for anvendelse
DK1758914T3 (da)	2008-03-17	Hidtil ukendte fluorglycosidderivater af pyrazoler, lægemidler indeholdende disse forbindelser og anvendelse heraf
IL176571A0 (en)	2006-10-31	Substituted azole derivatives, compositions, and methods of use
DK1713806T3 (da)	2013-08-05	Forbindelser og sammensætninger som proteinkinaseinhibitorer
DK1765327T3 (da)	2014-11-03	Forbindelser, sammensætninger og fremgangsmåder
IS7966A (is)	2005-07-29	Pyrazól og aðferðir við að búa þau til og notkun þeirra
EP1626717A4 (en)	2009-09-09	BENZIMIDAZOLE, COMPOSITIONS AND METHOD OF ADMINISTRATION CONTAINING SUCH COMPOUNDS
DK1901731T3 (da)	2011-06-14	Niacinreceptoragonister, sammensætninger indeholdende sådanne forbindelser og fremgangsmåder til behandling
DK1532145T3 (da)	2007-01-15	Pyrazolpræparater der er anvendelige som inhibitorer af GSK-3
ATE370142T1 (de)	2007-09-15	Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3
DK3305776T3 (da)	2019-12-09	Pyrrol-forbindelser som inhibitorer af erk-protein-kinaser og farmaceutiske sammensætninger, der indeholder disse forbindelser
DK1648426T3 (da)	2014-02-10	Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
NO20055211D0 (no)	2005-11-04	Anti-fungale forbindelser og fremgangsmater for anvendelse
DK1913001T3 (da)	2013-10-21	(r)-n-methylnaltrexon, fremgangsmåder til syntese og farmaceutisk anvendelse heraf
ATE404564T1 (de)	2008-08-15	Diazepinoindolderivate als kinaseinhibitoren
DK3524657T3 (da)	2021-02-01	Sammensætninger omfattende hfc-1234yf og hfc-32
DK2099796T3 (da)	2011-09-05	Aza-indolyl-forbindelser og fremgangsmåder for anvendelse
DK2069467T3 (da)	2014-10-20	Adskillende sammensætninger og fremgangsmåder til anvendelse
DK2617714T3 (da)	2016-06-27	Kemiske derivater af jasmonat, farmaceutiske præparater og fremgangsmåder til anvendelse deraf
NO20055686L (no)	2007-06-04	Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
DK1670769T3 (da)	2009-08-10	Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
NO20054876D0 (no)	2005-10-21	Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
IL179530A0 (en)	2007-05-15	Novel compounds, pharmaceutical compositions containing same and methods of use for same
DK1611115T3 (da)	2012-11-26	Benzothiazolderivatforbindelser, sammensætninger og anvendelser deraf